BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 33639888)

  • 21. Clinical observation of the adverse drug reactions caused by non-ionic iodinated contrast media: results from 109,255 cases who underwent enhanced CT examination in Chongqing, China.
    Li X; Chen J; Zhang L; Liu H; Wang S; Chen X; Fang J; Wang S; Zhang W
    Br J Radiol; 2015 Mar; 88(1047):20140491. PubMed ID: 25582519
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A systematic review of the prevalence and risk factors for adverse drug reactions in the elderly in the acute care setting.
    Alhawassi TM; Krass I; Bajorek BV; Pont LG
    Clin Interv Aging; 2014; 9():2079-86. PubMed ID: 25489239
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Frequency, types, severity, preventability and costs of Adverse Drug Reactions at a tertiary care hospital.
    Geer MI; Koul PA; Tanki SA; Shah MY
    J Pharmacol Toxicol Methods; 2016; 81():323-34. PubMed ID: 27109493
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of adverse drug reactions in medical intensive care units.
    Park S; In Y; Suh GY; Sohn K; Kim E
    Eur J Clin Pharmacol; 2013 Jan; 69(1):119-31. PubMed ID: 22673928
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hematologic adverse drug reactions leading to hospitalization among cancer patients: A retrospective case-control study.
    Chiou BL; Ho CC; Yang CC
    J Chin Med Assoc; 2020 Aug; 83(8):784-790. PubMed ID: 32168075
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incidence and patterns of adverse drug reactions among adult patients hospitalized in the University of Gondar comprehensive specialized hospital: A prospective observational follow-up study.
    Sendekie AK; Netere AK; Tesfaye S; Dagnew EM; Belachew EA
    PLoS One; 2023; 18(2):e0282096. PubMed ID: 36827307
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nature and prevalence of adverse drug reaction of antiretroviral medications in Halibet National Referral Hospital: a retrospective study.
    Hagos L; Fessehaye S; Anand IS
    BMC Pharmacol Toxicol; 2019 May; 20(1):24. PubMed ID: 31060603
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adverse drug reactions and associated patient characteristics in older community-dwelling adults: a 6-year prospective cohort study.
    Doherty AS; Boland F; Moriarty F; Fahey T; Wallace E
    Br J Gen Pract; 2023 Mar; 73(728):e211-e219. PubMed ID: 36823047
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incidence and predictors of all and preventable adverse drug reactions in frail elderly persons after hospital stay.
    Hanlon JT; Pieper CF; Hajjar ER; Sloane RJ; Lindblad CI; Ruby CM; Schmader KE
    J Gerontol A Biol Sci Med Sci; 2006 May; 61(5):511-5. PubMed ID: 16720750
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adverse drug reactions to anticoagulants in Spain: analysis of the Spanish National Hospital Discharge Data (2010-2013).
    Carrasco-Garrido P; Hernández-Barrera V; Esteban-Hernández J; Jiménez-Trujillo I; Álvaro-Meca A; López de Andrés A; de Miguel Diez J; Rodríguez Barrios JM; Muñoz Robles JA; Jiménez-García R
    BMJ Open; 2017 Jan; 7(1):e013224. PubMed ID: 28073793
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adverse Drug Reactions and Clinical Outcomes in Patients Initiated on Antiretroviral Therapy: A Prospective Cohort Study From Ethiopia.
    Bezabhe WM; Bereznicki LR; Chalmers L; Gee P; Kassie DM; Bimirew MA; Peterson GM
    Drug Saf; 2015 Jul; 38(7):629-39. PubMed ID: 26008986
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety and efficacy of the long-term adjuvant treatment of primary intermediate- to high-risk malignant melanoma (UICC/AJCC stage II and III) with a standardized fermented European mistletoe (Viscum album L.) extract. Results from a multicenter, comparative, epidemiological cohort study in Germany and Switzerland.
    Augustin M; Bock PR; Hanisch J; Karasmann M; Schneider B
    Arzneimittelforschung; 2005; 55(1):38-49. PubMed ID: 15727163
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Discrepancy between patient- and healthcare provider-reported adverse drug reactions in inflammatory bowel disease patients on biological therapy.
    Thomas PWA; Römkens TEH; West RL; Russel MGVM; Jansen JM; van Lint JA; Jessurun NT; Hoentjen F
    United European Gastroenterol J; 2021 Oct; 9(8):919-928. PubMed ID: 34077634
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cutaneous adverse drug reactions in the elderly: a retrospective analysis in Thailand.
    Tuchinda P; Chularojanamontri L; Sukakul T; Thanomkitti K; Nitayavardhana S; Jongjarearnprasert K; Uthaitas P; Kulthanan K
    Drugs Aging; 2014 Nov; 31(11):815-24. PubMed ID: 25193784
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of adverse drug reactions using hospital databases-a nationwide study in Portugal.
    Miguel A; Bernardo Marques ; Freitas A; Lopes F; Azevedo L; Pereira AC
    Pharmacoepidemiol Drug Saf; 2013 Aug; 22(8):907-13. PubMed ID: 23761351
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adverse Drug Reactions Spontaneously Reported at a Tertiary Care Hospital and Preventable Measures Implemented.
    Abu Esba LC; Al Mardawi G; AlJasser MI; Aljohani B; Abu Alburak A
    J Clin Pharm Ther; 2021 Apr; 46(2):460-469. PubMed ID: 33285001
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immune-related and adverse drug reactions to low versus high initial doses of Viscum album L. in cancer patients.
    Schad F; Thronicke A; Merkle A; Matthes H; Steele ML
    Phytomedicine; 2017 Dec; 36():54-58. PubMed ID: 29157828
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incidence and Economic Burden of Adverse Drug Reactions in Hospitalization: A Prospective Study in Korea.
    Seo B; Yang MS; Park SY; Park BY; Kim JH; Song WJ; Kwon HS; Chang YS; Cho YS; Kim SH; Kim TB
    J Korean Med Sci; 2023 Feb; 38(8):e56. PubMed ID: 36852852
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence and predictors of patients reporting adverse drug reactions to health care providers during oral targeted cancer treatment.
    Monestime S; Page R; Jordan WM; Aryal S
    J Am Pharm Assoc (2003); 2021; 61(1):53-59. PubMed ID: 33032945
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adverse drug reactions to antiretroviral therapy (ARVs): incidence, type and risk factors in Nigeria.
    Eluwa GI; Badru T; Agu KA; Akpoigbe KJ; Chabikuli O; Hamelmann C
    BMC Clin Pharmacol; 2012 Feb; 12():7. PubMed ID: 22369677
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.